DE60334225D1 - Mittel zum senken des blutglukosespiegels - Google Patents

Mittel zum senken des blutglukosespiegels

Info

Publication number
DE60334225D1
DE60334225D1 DE60334225T DE60334225T DE60334225D1 DE 60334225 D1 DE60334225 D1 DE 60334225D1 DE 60334225 T DE60334225 T DE 60334225T DE 60334225 T DE60334225 T DE 60334225T DE 60334225 D1 DE60334225 D1 DE 60334225D1
Authority
DE
Germany
Prior art keywords
ghs
antagonist
blood glucose
active ingredient
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334225T
Other languages
English (en)
Inventor
Akio Inui
Akihiro Asakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60334225D1 publication Critical patent/DE60334225D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/25Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60334225T 2002-07-05 2003-07-03 Mittel zum senken des blutglukosespiegels Expired - Lifetime DE60334225D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002197582 2002-07-05
PCT/JP2003/008482 WO2004004772A1 (ja) 2002-07-05 2003-07-03 糖尿病治療剤

Publications (1)

Publication Number Publication Date
DE60334225D1 true DE60334225D1 (de) 2010-10-28

Family

ID=30112403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334225T Expired - Lifetime DE60334225D1 (de) 2002-07-05 2003-07-03 Mittel zum senken des blutglukosespiegels

Country Status (15)

Country Link
US (1) US20060276381A1 (de)
EP (1) EP1541171B1 (de)
JP (1) JP5113320B2 (de)
KR (1) KR20050039829A (de)
CN (1) CN1681532A (de)
AT (1) ATE481133T1 (de)
AU (1) AU2003246261A1 (de)
BR (1) BR0312463A (de)
CA (1) CA2493906A1 (de)
DE (1) DE60334225D1 (de)
ES (1) ES2351856T3 (de)
MX (1) MXPA05000160A (de)
PL (1) PL374481A1 (de)
RU (1) RU2005102923A (de)
WO (1) WO2004004772A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006090767A1 (ja) * 2005-02-23 2006-08-31 Kyoto University 膵臓β細胞の再生促進剤及び膵臓β細胞におけるインスリン産生促進剤
US8536120B2 (en) 2006-04-28 2013-09-17 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
CN101646448B (zh) 2007-03-12 2017-02-08 雪印惠乳业株式会社 生长激素分泌促进剂
AU2008341160A1 (en) * 2007-12-21 2009-07-02 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using ipamorelin
WO2010022213A2 (en) * 2008-08-22 2010-02-25 Elixir Pharmaceuticals, Inc. Compositions and methods for preserving pancreatic islet mass
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
WO2011041584A2 (en) 2009-09-30 2011-04-07 President And Fellows Of Harvard College Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
US20110105389A1 (en) 2009-10-30 2011-05-05 Hoveyda Hamid R Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001228325A1 (en) * 2000-02-01 2001-08-14 Novo-Nordisk A/S Use of compounds for the regulation of food intake
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
WO2001087335A2 (en) * 2000-05-17 2001-11-22 Eli Lilly And Company Method for selectively inhibiting ghrelin action
US6967237B2 (en) * 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
WO2002060472A1 (en) * 2001-01-31 2002-08-08 Chugai Seiyaku Kabushiki Kaisha Remedies for hyponutrition status
US6949261B2 (en) * 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis

Also Published As

Publication number Publication date
BR0312463A (pt) 2005-04-26
EP1541171A1 (de) 2005-06-15
CA2493906A1 (en) 2004-01-15
WO2004004772A1 (ja) 2004-01-15
EP1541171A4 (de) 2008-04-09
ATE481133T1 (de) 2010-10-15
US20060276381A1 (en) 2006-12-07
PL374481A1 (en) 2005-10-31
MXPA05000160A (es) 2006-02-28
KR20050039829A (ko) 2005-04-29
RU2005102923A (ru) 2005-10-10
JP5113320B2 (ja) 2013-01-09
CN1681532A (zh) 2005-10-12
EP1541171B1 (de) 2010-09-15
JPWO2004004772A1 (ja) 2005-11-04
ES2351856T3 (es) 2011-02-11
AU2003246261A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
NO20072389L (no) Substituerte benzokinolizinderivater
NO20082445L (no) Neuropeptid-2 reseptor-agonister
ATE523504T1 (de) 1-thio-d-glucitolderivate
NO20070213L (no) Glucagon reseptorantagonister, fremstilling og terapeutiske anvendelser
NO20055887L (no) Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer
AR032065A1 (es) Derivados de glucopiranosiloxipirazol y composicion farmaceutica
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
NO20065260L (no) Tri(cyklo)substituerte amidforbindelser
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
ZA200410408B (en) N-substituted piperidine derivatives as serotonin receptor agents.
GB0201508D0 (en) Organic compounds
NO20081844L (no) Terapeutiske forbindelser
NO20071108L (no) Nye 4-benzylidenpiperidinderivater
WO2005082893A3 (en) Histamine h3 receptor antagonists, preparation and therapeutic uses
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
DK1926729T3 (da) Benzothiazolcyclobutylaminderivater og deres anvendelse som histamin-3-receptorligander
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
RS20060015A (en) Substituted thiazole- benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
NO20061702L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en ostrogen agonist/antagonist
DE60334225D1 (de) Mittel zum senken des blutglukosespiegels
WO2005058890A3 (en) Hydronopol derivatives as agonists on human orl1 receptors
AU2003260436A1 (en) Pyrimidine compounds